NCT00272831: The Use of Cilostazol in Patients With Diabetic Nephropathy |
|
|
| Completed | 4 | 62 | RoW | Cilostazol, Pletaal, Placebo | Chinese University of Hong Kong | Diabetes Mellitus, Type 2, Diabetes Complications | 12/07 | 12/07 | | |
NCT00823849: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker |
|
|
| Completed | 4 | 200 | RoW | Cilostazol, pletaal, Probucol, Changtai, Cilostazol+Probucol, Pletaal and Changtai, Control Group, Routine treatment | Otsuka Beijing Research Institute | Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | 08/09 | 03/10 | | |
NCT01515228: Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III) |
|
|
| Completed | 4 | 291 | RoW | Xience Prime, everolimus-eluting stent, Cilotax stent, paclitaxel with cilostazol dual drug eluting stent | CHEOL WHAN LEE, MD, PhD., CardioVascular Research Foundation, Korea | Coronary Artery Disease | 12/14 | 01/15 | | |
